# Atomvie Global Radiopharma Inc. – FDA Inspection, Mar 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/atomvie-global-radiopharma-inc/bb801417-85ba-418e-b4b6-b91100b52797
Source feed: FDA_Inspections

> FDA inspection 1045820 of Atomvie Global Radiopharma Inc., March 27, 2018. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR part 212. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1045820
- Company Name: Atomvie Global Radiopharma Inc.
- Inspection Date: 2018-03-27
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1100903 - 2019-07-19
- [FDA Inspection 843934 - 2013-07-26](https://www.keypedia.com/records/fda_inspections/atomvie-global-radiopharma-inc/d55a6a9e-0bb7-4611-9746-85fac64c0c7e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/atomvie-global-radiopharma-inc/fcd577a4-28d4-4a50-93dd-a5d7a1d6261a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c